KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Opko Health (OPK) Free Cash Flow (2016 - 2026)

Opko Health filings provide 17 years of Free Cash Flow readings, the most recent being -$21.1 million for Q1 2026.

On a quarterly basis, Free Cash Flow rose 43.99% to -$21.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$174.2 million, a 35.5% increase, with the full-year FY2025 number at -$190.8 million, up 8.48% from a year prior.
Free Cash Flow hit -$21.1 million in Q1 2026 for Opko Health, up from -$28.6 million in the prior quarter.
In the past five years, Free Cash Flow ranged from a high of $28.9 million in Q3 2023 to a low of -$158.7 million in Q3 2024.
Median Free Cash Flow over the past 5 years was -$37.8 million (2025), compared with a mean of -$40.5 million.
Biggest five-year swings in Free Cash Flow: skyrocketed 172.54% in 2023 and later tumbled 1054.92% in 2024.
Opko Health's Free Cash Flow stood at -$38.0 million in 2022, then dropped by 8.85% to -$41.3 million in 2023, then tumbled by 284.06% to -$158.7 million in 2024, then skyrocketed by 81.98% to -$28.6 million in 2025, then grew by 26.04% to -$21.1 million in 2026.
The last three reported values for Free Cash Flow were -$21.1 million (Q1 2026), -$28.6 million (Q4 2025), and -$37.8 million (Q3 2025) per Business Quant data.